Except for direct participation in clinical trials and post-approval activities such as disease education, patient involvement in the biopharmaceutical development process remains episodic and restricted. Although this is slowly changing, patient involvement at each step of a product lifecycle is not yet standard practice for most companies. WHY Engaging Patients is Key for Pharma’s Success…
Medical marijuana – or cannabis – is one of the hottest topics in oncology right now. This is especially true as more and more countries and states have legalized, or are working towards legalizing, medical cannabis. Some patient groups and alternative medicine providers view marijuana as a miracle treatment for a range of conditions. However,…
As a result of rising healthcare costs, there have been widespread efforts to reform healthcare delivery worldwide. To succeed in this, many hospitals, health systems, and independent clinics are turning to clinical integration. Clinical Integration – What is it and Why Do We Need it? Overview of Clinical Integration. Source: Goldwater, J., Yuhasz, L….
Did you know that our online platform—the Impetus InSite Platform®—has multiple other uses in addition to virtual advisory boards, working groups, and team collaboration? Among others, these include continuing medical education (CME)! In this case study, we summarize the outcomes from a series of CME touchpoints conducted by one of our dermatology clients and executed…
With many patents about to expire in coming years, the field of biologics in oncology is about to change dramatically. Biologics are predicted to comprise over one-quarter of the pharmaceutical market by 2020. Currently, almost half of all biologics sales come from 11 major agents. All of these will have their patent expire in the…
We have previously discussed the potential roles of real-world data (RWD) and real-world evidence (RWE) for drug access. However, the precise roles of RWE in facilitating regulatory and reimbursement decisions remain poorly defined. Specifically, the types of studies, quality of data, and level of evidence to consider in the reimbursement decision process remain largely unclear….
Did you know that the top 10 highest grossing drugs in the United States only help between 4-25% of patients who take them? In addition, some drugs may even be harmful to certain minorities because of bias towards non-Hispanic white participants in traditional clinical trials. These statistics should be worrisome to physicians, patients, and payers….
What is Bionics and Why Should You Care? Bionics – also known as biomechatronics – is the study of mechanical systems that function like living organisms or parts thereof. More specifically, human bionics is an applied interdisciplinary science that integrates mechanical elements or devices with biological systems such as human bones, muscles, internal organs, and…
Artificial intelligence, or AI for short, is one of the most highly anticipated digital healthcare technologies. While the concept of AI may still seem futuristic to some, the era of machine learning is already here. Uptake in pharma has been relatively slow compared to in other industries. However, this is gradually changing. AI is developing…